Satellos Bioscience MSLE
NASDAQ MSLE
$8.50 -0.10 (-1.16%)
At close: Sep 30, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Other Operating Expenses (2024 - 2025)

Updated

Satellos Bioscience's Other Operating Expenses was -$26.46 million in the quarter ended Dec 31, 2025, compared with -$20.4 million a year earlier.

Analysis

Satellos Bioscience (MSLE) Other Operating Expenses (2024 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Other Operating Expenses at Satellos Bioscience came in at -$52.92 million.

  • In earlier years, Other Operating Expenses was -$39.81 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Satellos Bioscience 131.40 Mn 131.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -26.46 Mn
Dec 31, 2024 -20.40 Mn
API Access

Satellos Bioscience Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=MSLE&period=max&api_key=YOUR_API_KEY